The market found its footing last week, with the S&P 500 gaining roughly 1.9% over the past five days after a volatile stretch.
But a broad rebound doesn’t make valuation any less important. A rising stock isn’t automatically expensive, just as a falling one isn’t necessarily a bargain. What matters is what investors are actually getting for the price they’re paying.
That distinction becomes particularly important when markets are moving quickly. Plenty of seemingly cheap stocks deserve their discounts, while others can pair attractive valuations with strong fundamentals and improving business results.
The challenge is separating one group from the other.
Fortunately, there’s a way to make that distinction a lot easier…
Our in-house quant system takes a look at 4,600 stocks each day and grades them through the lens of 115 metrics, split across 7 categories. That data is boiled down into a simple, straightforward metric. That is a stock’s Zen Rating.
Our top grade, a Zen Rating of A, equivalent to a Strong Buy recommendation, is reserved for those tickers that rank in the top 5% on overall fundamental strength. A bit of quick math tells us that 5% of 4,600 is 230 — and while that is a good start, that is still plenty of tickers to consider on any given day.
That’s not the end of it, however. You can speed things along by taking a look at one of our exclusive Zen Strategies.
This week, the spotlight is on a portfolio that has returned 37.06% since the start of the year, compared to just 10.25% for the S&P 500. In the last 30 days, it has netted a 15.23% return … blowing the benchmark index’s 2.36% loss in the same timeframe out of the water. We’re talking about our Value Stock Strategy.
Without further ado, let’s take a closer look at 3 interesting tickers from this week’s portfolio.
PBF Energy is one of the largest independent refiners in the U.S., producing gasoline, diesel, heating oil, jet fuel, lubricants, and other petroleum products. PBF currently ranks in the top 1% of all the stocks we track, giving it a Zen Rating of A — and it’s also the 8th highest-rated stock in the A-rated Oil & Gas Refining & Marketing industry.
The fundamental profile is strong across most of the board. Artificial Intelligence ranks in the top 29%, followed by Sentiment at the top 28% — which is our model picking up on subtle patterns that hint at outperformance as well as strong smart money interest. Momentum comes in at the top 12%, Growth at the top 8%, and Financials at the top 7%. Value is the standout of the bunch … There, PBF ranks in the top 1% of everything we track. With shares trading at just 3.13 times earnings and 0.24 times sales, it’s not difficult to see why. Safety is the one area that trails the rest of the profile.
The latest quarter adds plenty of support to the broader picture. PBF delivered EPS of $12.78 against an $11.12 estimate, following another sizable beat the quarter before. PBF also recently increased its quarterly dividend by roughly 18%.
Ironwood Pharmaceuticals develops and commercializes treatments for gastrointestinal disorders, with LINZESS serving as the company’s primary commercial product. IRWD now ranks in the top 5% of all the stocks we track, giving it a Zen Rating of A … and it sits as the 6th highest-rated ticker out of 47 in the B-rated Pharmaceutical industry.
Artificial Intelligence ranks in the top 19% of the stocks we track, followed by Sentiment at the top 10%. Things get considerably more impressive from there — both Financials and Value rank in the top 1% of everything we track. Growth and Momentum come in around average, and Safety is the one area that trails the rest of the profile, but the strength of those top scores is enough to push IRWD firmly into A-rated territory.
The valuation is particularly difficult to ignore. IRWD trades at a PEG ratio of 0.28x. A discounted cash flow model also estimates fair value at approximately $10.52 per share — more than double the current $4.83 stock price.
Ironwood earned $0.36 per share against an estimate of $0.32 in its latest report, with EPS climbing roughly 57% year over year. Management also raised its full-year outlook for the second consecutive quarter.
Ultrapar is a Brazilian holding company with businesses spanning fuel distribution, liquefied petroleum gas, and related energy infrastructure. At just $5.82 per share, UGP currently ranks in the top 3% of all the stocks we track, giving it a Zen Rating of A — and it’s also the 11th highest-rated stock in the A-rated Oil & Gas Refining & Marketing industry.
The Component Grades paint a strong, well-rounded picture without any particularly strong deficiencies. Safety ranks in the top 34%, followed closely by Financials at the top 33%. Artificial Intelligence comes in at the top 15%, Momentum at the top 11%, and Growth at the top 10%. Value leads the way at the top 2% of everything we track. Sentiment sits closer to the middle of the pack, but there’s very little else to dislike from a quantitative standpoint.
There’s plenty to like from a traditional valuation perspective as well. Shares trade at a PEG ratio of 0.73x. UGP also carries a dividend yield of roughly 3.3%, adding a handy income component to an already inexpensive stock.
The company’s latest earnings report provides the fresh catalyst. UGP delivered EPS of $0.42 against a $0.27 estimate, beating expectations by more than 50%. Earnings also increased roughly 248% from the same period last year, and the report marked the company’s third consecutive earnings beat.
The 3 stocks highlighted above are just a fraction of what you get from our proven Value Stock Strategy.
That’s because each day our system recalibrates — and Zen Strategies members get access to the top 7 Value stocks based on 115 different parameters that point to outperformance.
See all Top 7 Value Stocks here >
However, maybe none of the stocks you’ve seen here have caught your eye. Perhaps you would like to see all 11 of our market-beating strategies including Growth, Momentum, Income, and our coveted AI Factor model.
Each featuring the top 7 stocks.
Each featuring tremendous performance.
We spell it all out in this timely presentation below that lives up to its name:
10 Minutes a Month to Beat the Market >
What to Do Next?
Want to get in touch? Email us at news@wallstreetzen.com.